Clinical Trials Logo

Exfoliation Syndrome clinical trials

View clinical trials related to Exfoliation Syndrome.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04609345 Not yet recruiting - Ocular Hypertension Clinical Trials

Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients

Start date: November 2020
Phase:
Study type: Observational

This is a prospective, multi-centre, cross sectional observational study to determine the prevalence of ocular surface disease (OSD) in glaucoma patients, nationwide. The study also analyses sub group of OSD prevalence, stratified according to the treatment types (i.e. preserved, preservative-free, and combination of preservative-free and preserved eyedrops), and illustrates the patient perspective on OSD.

NCT ID: NCT04440527 Not yet recruiting - Clinical trials for Primary Open Angle Glaucoma

Intraocular Pressure After Preserflo / Innfocus Microshunt Implantation vs Trabeculectomy

PAINT
Start date: July 22, 2020
Phase: N/A
Study type: Interventional

The aim of this project is to compare trabeculectomy with Preserflo / Innfocus Microshunt in patients with Primary Angle Open Glaucoma and Pseudoexfoliation Glaucoma regarding the reduction of intraocular pressure.

NCT ID: NCT04416724 Not yet recruiting - Clinical trials for Pseudoexfoliation Glaucoma

Phacoemulsification vs SLT as Initial Treatment for Pseudoexfoliation Glaucoma

CANPEX1
Start date: April 2021
Phase: N/A
Study type: Interventional

The Canadian Pseudoexfoliation Glaucoma Study 1 is a randomized clinical trial that aims to compare two initial treatment options - Selective Laser Trabeculoplasty (SLT) and Phacoemulsification (PHACO) - in newly diagnosed patients with pseudoexfoliation and need to lower the intraocular pressure. Patients with pseudoexfoliation and a recent decision to lower the intraocular pressure, who also have early asymptomatic lens opacification will be recruited and randomized to receive either SLT or PHACO. Patients will be followed for 2 years according to a target IOP protocol based on the Canadian Ophthalmological Society Glaucoma guidelines. Patients who do not achieve the target IOP with the initial randomization procedure will receive IOP lowering medications. The main outcome of interest will be the proportion of subjects who need IOP lowering medications after 2 years. Secondary outcomes include IOP reduction, time to need medications, patient reported outcomes in terms of visual function, and occurrence of adverse effects. To obtain longer follow-up information beyond two years, a chart review will be done 5 and 10 years after randomization.

NCT ID: NCT04274634 Not yet recruiting - Cataract Clinical Trials

The Oscillation of Crystalline and Intraocular Lenses

Start date: October 2020
Phase:
Study type: Observational

The crystalline lens of the human eye helps to sharpen vision. There can be issues with the support/stability of the lens. This could be seen with the naked eye of an external observer or with the use of a slit lamp. Certain eye conditions can predispose to issues with lens stability. If patients have stability issues with their natural lens- this would be termed as "phakodonesis". However, in patients who have had prior cataract surgery with implantation of an artificial lens (IOL)- this would be termed as "pseudophakodonesis". Eye conditions such as pseudoexfoliation or Marfan-syndrome can lead to unstable lens support- this can be detected if there are advanced stability issues. However, small instability in the eye's would not be detected with present descriptive methods. The authors have designed a high-speed camera which is able to detect stability of the lens, especially during eye movements. The high-speed camera can detect variation in the change of light reflex from the lens and calculate the amount of lens instability/oscillation. The results (in normal eyes) of this high-speed camera has already been published in a peer-review journal. It is non-contact and measures lens movement. The test lasts less than 5 minutes. Further research is required to assess the amount of lens oscillation (wobbling) in different eye populations - patients with previous cataract surgery (an artificial implant is used to replace the lens) or eye conditions (such as pseudoexfoliation, Marfan syndrome). The amount of lens stability has a role in the planning of further intraocular surgery - especially cataract extraction - however, at present, there is no approved quantitative measurement for this. Participants will be recruited through Anglia Ruskin University (educational establishment), local community groups, and through Southend University Hospital eye clinics (NHS organisation). Participants' data will remain anonymous.

NCT ID: NCT03741153 Not yet recruiting - Lens Diseases Clinical Trials

Association Between Pseudoexfoliation Syndrome and Diabetes Mellitus

Start date: January 2019
Phase:
Study type: Observational

Pseudoexfoliation syndrome (PEX) is characterized by the deposition of a distinctive fibrillar material in the anterior segment of the eye and was first described in 1917 by Lindberg. It is frequently associated with open angle glaucoma, known as pseudoexfoliation glaucoma, which is one of the most common identifiable forms of secondary open angle glaucoma worldwide. Despite extensive research, the exactchemical nature of the fibrillar material is unknown. It is believed to be secreted multifocally in the iris pigment epithelium, the ciliary epithelium, and the peripheral anterior lens epithelium.

NCT ID: NCT03265457 Not yet recruiting - Clinical trials for Pseudoexfoliation Syndrome

The Endothelial Count in Pxf

Start date: October 1, 2018
Phase:
Study type: Observational

Pseudoexfoliation Syndrome Is a common disorder in Egypt. IT is one of the common causes of coexisting cataract and glaucoma. It may be associated with a less than normal endothelial count.